Rockwell Medical has announced positive results from PRIME clinical study of iron-delivery drug, Soluble Ferric Pyrophosphate (SFP), demonstrating statistically significant 37% reduction in erythropoietin stimulating agents (ESA) dose. ...
Tags: Rockwell, iron delivery drug, Medical